We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+40.86%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$103M
AUM Growth
+$18.3M
Cap. Flow
+$12.1M
Cap. Flow %
11.77%
Top 10 Hldgs %
44.11%
Holding
78
New
16
Increased
27
Reduced
9
Closed
5

Top Buys

Rank Stock Value
1
ARKO icon
ARKO Corp
ARKO
+$3.18M
2
CHRS icon
Coherus Oncology
CHRS
+$1.48M
3
CVS icon
CVS Health
CVS
+$1.42M
4
B
Barrick Mining
B
+$911K
5
TALO icon
Talos Energy
TALO
+$808K

Top Sells

Rank Stock Value
1
PLPC icon
Preformed Line Products
PLPC
+$1.53M
2
OSPN icon
OneSpan
OSPN
+$1.23M
3
CYTK icon
Cytokinetics
CYTK
+$925K
4
TAST
Carrols Restaurant Group, Inc.
TAST
+$793K
5
ARKOW
ARKO Corp Warrant
ARKOW
+$597K

Sector Composition

Rank Sector Weight
1 Healthcare 42%
2 Industrials 9.41%
3 Energy 9.38%
4 Financials 8.51%
5 Consumer Discretionary 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTRS icon
26
Viatris
VTRS
$18.8B
$1.25M 1.22%
125,000
– –
DIT icon
27
AMCON Distributing
DIT
$1.22M 1.19%
9,000
– –
RBCAA icon
28
Republic Bancorp
RBCAA
$1.86B
$1.17M 1.14%
27,500
– –
SVC
29
Service Properties Trust
SVC
$1.02B
$1.13M 1.1%
26,000
+2,000
+8% +$87.8K
SFE
30
DELISTED
Safeguard Scientifics, Inc.
SFE
$1.11M 1.08%
671,671
– –
USAP
31
DELISTED
Universal Stainless & Alloy
USAP
$1.05M 1.03%
75,000
-40,000
-35% -$425K
WKC icon
32
World Kinect Corp
WKC
$1.81B
$1.03M 1.01%
50,000
– –
VTOL icon
33
Bristow Group
VTOL
$1.3B
$1.01M 0.98%
35,000
-2,500
-7% -$59.6K
SABR icon
34
Sabre
SABR
$888M
$957K 0.93%
300,000
– –
AVIR icon
35
Atea Pharmaceuticals
AVIR
$430M
$935K 0.91%
250,000
-75,000
-23% -$281K
BCDA icon
36
BioCardia
BCDA
$17.4M
$916K 0.89%
22,867
+934
+4% +$28.8K
AMRX icon
37
Amneal Pharmaceuticals
AMRX
$6.11B
$853K 0.83%
275,000
+125,000
+83% +$266K
B
38
Barrick Mining
B
$75.1B
$847K 0.83%
+50,000
New +$911K
ADSK icon
39
Autodesk
ADSK
$55B
$818K 0.8%
+4,000
New +$800K
FCX icon
40
Freeport-McMoran
FCX
$110B
$800K 0.78%
+20,000
New +$762K
RNAC icon
41
Cartesian Therapeutics
RNAC
$290M
$784K 0.76%
23,333
+3,333
+17% +$119K
BATL icon
42
Battalion Oil
BATL
$75M
$771K 0.75%
135,000
+10,000
+8% +$66.1K
SPPI
43
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$768K 0.75%
800,000
+125,000
+19% +$124K
WBD icon
44
Warner Bros
WBD
$72.1B
$752K 0.73%
+60,000
New +$779K
TRC icon
45
Tejon Ranch
TRC
$438M
$688K 0.67%
40,000
-20,000
-33% -$348K
APA icon
46
APA Corp
APA
$14.9B
$683K 0.67%
+20,000
New +$698K
PK icon
47
Park Hotels & Resorts
PK
$3.19B
$641K 0.63%
50,000
+30,000
+150% +$383K
ELTX icon
48
Elicio Therapeutics
ELTX
$74.6M
$618K 0.6%
65,000
-15,000
-19% -$138K
PAAS icon
49
Pan American Silver
PAAS
$21.9B
$583K 0.57%
+40,000
New +$661K
HRTX icon
50
Heron Therapeutics
HRTX
$62M
$580K 0.57%
500,000
+150,000
+43% +$268K
1
2
3 4

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
BCI
Blue Capital Inc Omaha, Nebraska $158M AUM 33.7% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

CM Management's Q2 2023 Portfolio in Review

As of Q2 2023, CM Management held 78 positions worth $103M, up 22% from $84.2M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

CM Management deployed $12.1M of net new capital in Q2 2023, opening 16 new positions and adding to 27 existing holdings. Its largest new stake was CVS Health: 20,000 shares worth $1.38M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 36% a quarter earlier, followed by Industrials and Energy.

On the sell side, the largest reduction was Preformed Line Products, an estimated $1.53M trimmed.

  • CM Management's largest Q2 2023 buy was CVS Health: 20,000 shares worth $1.38M.
  • CM Management added most to ARKO Corp in Q2 2023, an estimated $3.18M increase.
  • CM Management's biggest Q2 2023 reduction was Preformed Line Products, cutting an estimated $1.53M.
  • CM Management fully exited OneSpan in Q2 2023, selling an estimated $1.23M.
  • CM Management's ten largest holdings make up 44% of its $103M portfolio in Q2 2023.
  • CM Management opened 16 new positions and closed 5 in Q2 2023.
  • CM Management's portfolio value rose 22% quarter-over-quarter to $103M.

Based on CM Management's 13F filing for Q2 2023, filed 4 Aug 2023.